PL378576A1 - Wytwarzanie podstawionych chinazolin - Google Patents
Wytwarzanie podstawionych chinazolinInfo
- Publication number
- PL378576A1 PL378576A1 PL378576A PL37857604A PL378576A1 PL 378576 A1 PL378576 A1 PL 378576A1 PL 378576 A PL378576 A PL 378576A PL 37857604 A PL37857604 A PL 37857604A PL 378576 A1 PL378576 A1 PL 378576A1
- Authority
- PL
- Poland
- Prior art keywords
- preparation
- substituted quinazolines
- quinazolines
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44509503P | 2003-02-05 | 2003-02-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL378576A1 true PL378576A1 (pl) | 2006-05-02 |
Family
ID=32850969
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL378576A PL378576A1 (pl) | 2003-02-05 | 2004-02-03 | Wytwarzanie podstawionych chinazolin |
Country Status (18)
Country | Link |
---|---|
US (1) | US20040158065A1 (pl) |
EP (1) | EP1618095A2 (pl) |
JP (1) | JP2006517959A (pl) |
KR (1) | KR20050095916A (pl) |
CN (1) | CN1745073A (pl) |
AR (1) | AR043027A1 (pl) |
AU (1) | AU2004209452A1 (pl) |
BR (1) | BRPI0407249A (pl) |
CA (1) | CA2514933A1 (pl) |
MX (1) | MXPA05007831A (pl) |
NL (3) | NL1025414C2 (pl) |
PA (1) | PA8595201A1 (pl) |
PE (1) | PE20040945A1 (pl) |
PL (1) | PL378576A1 (pl) |
RU (1) | RU2005122322A (pl) |
TW (1) | TW200420544A (pl) |
UY (1) | UY28177A1 (pl) |
WO (1) | WO2004069791A2 (pl) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SK287010B6 (sk) | 1999-06-21 | 2009-09-07 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Bicyklické heterocyklické zlúčeniny, spôsob ich prípravy, farmaceutický prostriedok s ich obsahom a ich použitie |
US7019012B2 (en) * | 2000-12-20 | 2006-03-28 | Boehringer Ingelheim International Pharma Gmbh & Co. Kg | Quinazoline derivatives and pharmaceutical compositions containing them |
AU2004264937B2 (en) * | 2003-08-14 | 2010-04-29 | Array Biopharma Inc. | Quinazoline analogs as receptor tyrosine kinase inhibitors |
US7501427B2 (en) | 2003-08-14 | 2009-03-10 | Array Biopharma, Inc. | Quinazoline analogs as receptor tyrosine kinase inhibitors |
DE10349113A1 (de) * | 2003-10-17 | 2005-05-12 | Boehringer Ingelheim Pharma | Verfahren zur Herstellung von Aminocrotonylverbindungen |
JP4205757B2 (ja) * | 2004-05-06 | 2009-01-07 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | 4−フェニルアミノ−キナゾリン−6−イル−アミド |
KR100735639B1 (ko) * | 2004-12-29 | 2007-07-04 | 한미약품 주식회사 | 암세포 성장 억제 효과를 갖는 퀴나졸린 유도체 및 이의제조방법 |
KR100832594B1 (ko) * | 2005-11-08 | 2008-05-27 | 한미약품 주식회사 | 다중저해제로서의 퀴나졸린 유도체 및 이의 제조방법 |
WO2007054550A1 (en) | 2005-11-11 | 2007-05-18 | Boehringer Ingelheim International Gmbh | Quinazoline derivatives for the treatment of cancer diseases |
DK1971601T3 (da) * | 2005-11-15 | 2010-02-08 | Array Biopharma Inc | N4-phenyl-quinazolin-4-aminderivater og beslægtede forbindelser som ERBB Type 1-receptortyrosinkinase-inhibitorer til behandling af hyperproliferative sygdomme |
BRPI0717586A2 (pt) * | 2006-09-18 | 2013-10-29 | Boehringer Ingelheim Int | Método para tratar câncer apresentando mutações do egfr |
CA2698944C (en) | 2007-09-10 | 2015-06-16 | Curis, Inc. | Tartrate salts or complexes of quinazoline based egfr inhibitors containing a zinc binding moiety |
WO2009094216A1 (en) * | 2008-01-22 | 2009-07-30 | Concert Pharmaceuticals Inc. | Derivatives of gefitinib |
WO2009094210A1 (en) * | 2008-01-22 | 2009-07-30 | Concert Pharmaceuticals Inc. | Vandetanib derivatives |
SG193859A1 (en) * | 2008-09-05 | 2013-10-30 | Celgene Avilomics Res Inc | Algorithm for designing irreversible inhibitors |
WO2011003853A2 (en) | 2009-07-06 | 2011-01-13 | Boehringer Ingelheim International Gmbh | Process for drying of bibw2992, of its salts and of solid pharmaceutical formulations comprising this active ingredient |
KR20120093220A (ko) | 2009-09-16 | 2012-08-22 | 아빌라 테라퓨틱스, 인크. | 단백질 키나아제 컨쥬게이트 및 인히비터 |
KR20130067487A (ko) | 2009-12-30 | 2013-06-25 | 아빌라 테라퓨틱스, 인크. | 단백질의 리간드-지정 공유 변형 |
CN102382106A (zh) * | 2010-08-30 | 2012-03-21 | 黄振华 | 苯胺取代的喹唑啉衍生物 |
CN102898386B (zh) * | 2011-07-27 | 2015-07-29 | 上海医药集团股份有限公司 | 喹唑啉衍生物、其制备方法、中间体、组合物及其应用 |
CN103874696B (zh) | 2011-10-12 | 2015-06-03 | 苏州韬略生物科技有限公司 | 作为激酶抑制剂的喹唑啉衍生物及其使用方法 |
EP2847186B1 (en) | 2012-05-07 | 2017-08-09 | Teligene Ltd. | Substituted aminoquinazolines useful as kinases inhibitors |
CN103965120B (zh) * | 2013-01-25 | 2016-08-17 | 上海医药集团股份有限公司 | 喹啉及喹唑啉衍生物、制备方法、中间体、组合物及应用 |
CN103242244B (zh) * | 2013-05-16 | 2015-03-25 | 苏州明锐医药科技有限公司 | 一种卡奈替尼的制备方法 |
JP6139782B2 (ja) | 2013-05-21 | 2017-05-31 | チャンスー メドリューション リミテッド | 置換ピラゾロピリミジン化合物、及びその薬学的に許容される塩、並びにこれらの溶媒和物、立体異性体、及び互変異性体、並びにこれらを含む医薬組成物 |
US9242965B2 (en) | 2013-12-31 | 2016-01-26 | Boehringer Ingelheim International Gmbh | Process for the manufacture of (E)-4-N,N-dialkylamino crotonic acid in HX salt form and use thereof for synthesis of EGFR tyrosine kinase inhibitors |
EP3517529B1 (en) * | 2016-09-23 | 2022-03-23 | Shanghai Pharmaceuticals Holding Co., Ltd. | Salt of quinazoline derivative, preparation method therefor and application thereof |
EP3762368B1 (en) | 2018-03-08 | 2022-01-26 | Incyte Corporation | Aminopyrazine diol compounds as pi3k-y inhibitors |
US11046658B2 (en) | 2018-07-02 | 2021-06-29 | Incyte Corporation | Aminopyrazine derivatives as PI3K-γ inhibitors |
KR20210137422A (ko) | 2018-09-25 | 2021-11-17 | 블랙 다이아몬드 테라퓨틱스, 인코포레이티드 | 티로신 키나아제 억제제로서의 퀴나졸린 유도체, 조성물, 이들의 제조 방법 및 이들의 용도 |
BR112021016960A2 (pt) * | 2019-03-07 | 2021-11-23 | BioNTech SE | Processo para a preparação de uma imidazoquinolina substituída |
US20240246940A1 (en) * | 2021-04-22 | 2024-07-25 | Voronoi Inc. | Heteroaryl derivative compound and use thereof |
WO2023044364A1 (en) | 2021-09-15 | 2023-03-23 | Enko Chem, Inc. | Protoporphyrinogen oxidase inhibitors |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0892789T4 (da) * | 1996-04-12 | 2010-04-06 | Warner Lambert Co | Irreversible inhibitorer af tyrosin kinaser |
US6664390B2 (en) * | 2000-02-02 | 2003-12-16 | Warner-Lambert Company Llc | Method for the simplified production of (3-chloro-4-fluorophenyl)-[7-(3-morpholin-4-yl-propoxy)-6-nitro-quinazoline-4-yl]-amine or (3-chloro-4-fluorophenyl)-[7-(3-morpholin-4-yl-propoxy)-6-amino-quinazoline-4-yl]-amine |
DE10009267A1 (de) * | 2000-02-26 | 2001-08-30 | Goedecke Ag | Verfahren zur einfachen Herstellung von (3-Chlor-4-fluor-phenyl)-[7-(3-morpholin-4-yl-propoxy)-6-nitro-quinazolin-4-yl]-amin bzw. (3-Chlor-4-fluor-phenyl)-[7-(3-morpholin-4-yl-propoxy)-6-amino-quinazolin-4-yl]-amin |
US6627634B2 (en) * | 2000-04-08 | 2003-09-30 | Boehringer Ingelheim Pharma Kg | Bicyclic heterocycles, pharmaceutical compositions containing them, their use, and processes for preparing them |
DE10063435A1 (de) * | 2000-12-20 | 2002-07-04 | Boehringer Ingelheim Pharma | Chinazolinderviate,diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
-
2004
- 2004-02-02 PE PE2004000120A patent/PE20040945A1/es not_active Application Discontinuation
- 2004-02-03 TW TW093102396A patent/TW200420544A/zh unknown
- 2004-02-03 PL PL378576A patent/PL378576A1/pl not_active Application Discontinuation
- 2004-02-03 CA CA002514933A patent/CA2514933A1/en not_active Abandoned
- 2004-02-03 KR KR1020057014036A patent/KR20050095916A/ko not_active Application Discontinuation
- 2004-02-03 AU AU2004209452A patent/AU2004209452A1/en not_active Abandoned
- 2004-02-03 JP JP2006502417A patent/JP2006517959A/ja not_active Abandoned
- 2004-02-03 MX MXPA05007831A patent/MXPA05007831A/es unknown
- 2004-02-03 WO PCT/IB2004/000321 patent/WO2004069791A2/en active Application Filing
- 2004-02-03 CN CNA2004800032079A patent/CN1745073A/zh active Pending
- 2004-02-03 RU RU2005122322/04A patent/RU2005122322A/ru not_active Application Discontinuation
- 2004-02-03 BR BR0407249-9A patent/BRPI0407249A/pt not_active IP Right Cessation
- 2004-02-03 EP EP04707601A patent/EP1618095A2/en not_active Withdrawn
- 2004-02-04 AR ARP040100350A patent/AR043027A1/es unknown
- 2004-02-04 US US10/771,774 patent/US20040158065A1/en not_active Abandoned
- 2004-02-04 UY UY28177A patent/UY28177A1/es not_active Application Discontinuation
- 2004-02-05 NL NL1025414A patent/NL1025414C2/nl not_active IP Right Cessation
- 2004-02-05 PA PA20048595201A patent/PA8595201A1/es unknown
-
2005
- 2005-08-18 NL NL1029762A patent/NL1029762C2/nl not_active IP Right Cessation
- 2005-08-18 NL NL1029763A patent/NL1029763C2/nl not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NL1029762A1 (nl) | 2005-10-13 |
US20040158065A1 (en) | 2004-08-12 |
NL1029763C2 (nl) | 2006-03-06 |
MXPA05007831A (es) | 2005-10-18 |
NL1029762C2 (nl) | 2006-03-06 |
WO2004069791A2 (en) | 2004-08-19 |
AR043027A1 (es) | 2005-07-13 |
NL1025414C2 (nl) | 2005-11-01 |
CN1745073A (zh) | 2006-03-08 |
NL1025414A1 (nl) | 2004-08-06 |
RU2005122322A (ru) | 2006-03-10 |
WO2004069791A3 (en) | 2004-12-16 |
JP2006517959A (ja) | 2006-08-03 |
PE20040945A1 (es) | 2004-12-14 |
CA2514933A1 (en) | 2004-08-19 |
AU2004209452A1 (en) | 2004-08-19 |
TW200420544A (en) | 2004-10-16 |
PA8595201A1 (es) | 2004-09-16 |
BRPI0407249A (pt) | 2006-01-31 |
UY28177A1 (es) | 2004-09-30 |
EP1618095A2 (en) | 2006-01-25 |
KR20050095916A (ko) | 2005-10-04 |
NL1029763A1 (nl) | 2005-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL378576A1 (pl) | Wytwarzanie podstawionych chinazolin | |
ZA200605348B (en) | Solid forms of anti-EGFR-antibodies | |
GB0322409D0 (en) | Quinazoline derivatives | |
IL174534A0 (en) | Quinazoline derivatives | |
IL174257A0 (en) | Quinazoline derivatives | |
ZA200602264B (en) | Quinazoline derivatives | |
GB0321648D0 (en) | Quinazoline derivatives | |
IL175421A0 (en) | Quinazoline derivatives | |
EP1745573A4 (en) | PROCESS FOR PREPARING 2-DEOXY-BETA-L-NUCLEOSIDES | |
IL174390A0 (en) | Quinazoline derivatives | |
GB0421149D0 (en) | Preparation of oxycodone | |
GB0200744D0 (en) | Preparation of nanoparticles | |
GB0330002D0 (en) | Quinazoline derivatives | |
ZA200603039B (en) | Quinazoline derivatives | |
GB0304555D0 (en) | Compounds and methods of manufacture | |
AU2003298725A8 (en) | Preparation of metallotexaphyrins | |
GB0321620D0 (en) | Quinazoline derivatives | |
ZA200505214B (en) | Preparation of quinapril hydrochloride | |
PL377902A1 (pl) | Nowe zastosowanie kompleksu fosfor-azot-metal | |
AU152108S (en) | Set of pavers | |
IL165356A0 (en) | Preparation of 4-haloalkylkylnicotinamides | |
GB0318915D0 (en) | Construction of aerials | |
TW561865U (en) | Improvement of curtain | |
TW553243U (en) | Structure of clotheshanger | |
TW582219U (en) | Improved structure of flabellum |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |